Jane Street Group LLC purchased a new stake in Longeveron Inc. (NASDAQ:LGVN – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 20,493 shares of the company’s stock, valued at approximately $35,000. Jane Street Group LLC owned 0.14% of Longeveron at the end of the most recent reporting period.
Separately, Virtu Financial LLC bought a new position in Longeveron in the 4th quarter valued at $53,000. Institutional investors and hedge funds own 10.01% of the company’s stock.
Longeveron Price Performance
Shares of NASDAQ:LGVN opened at $1.27 on Tuesday. The firm has a fifty day moving average price of $1.41 and a two-hundred day moving average price of $1.60. Longeveron Inc. has a one year low of $0.77 and a one year high of $6.40. The company has a market cap of $18.96 million, a price-to-earnings ratio of -0.20 and a beta of 0.22.
Wall Street Analyst Weigh In
Get Our Latest Analysis on Longeveron
Longeveron Company Profile
Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company’s lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors.
Further Reading
- Five stocks we like better than Longeveron
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Palantir Stock Holds Support, Despite Political Backlash
- What Are the U.K. Market Holidays? How to Invest and Trade
- 3 Tightly-Held Growth Stocks Set Up for Short Squeezes
- What is the Dow Jones Industrial Average (DJIA)?
- Science Applications International Is a Wicked Hot Buy in June
Receive News & Ratings for Longeveron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longeveron and related companies with MarketBeat.com's FREE daily email newsletter.